Cargando…

Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis

Central nervous system (CNS) complications can occur in 9%–15% of patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The clinical manifestations of the CNS complications are non-specific, with most of them being disturbances of consciousness, convulsions, headaches, fever...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Binglei, Zhou, Jian, Gui, Ruirui, Li, Zhen, Zu, Yingling, Wang, Juan, Yu, Fengkuan, Zhang, Yanli, Zhao, Huifang, Ji, Zhenyu, Song, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476959/
https://www.ncbi.nlm.nih.gov/pubmed/34595132
http://dx.doi.org/10.3389/fcimb.2021.720132
_version_ 1784575736590368768
author Zhang, Binglei
Zhou, Jian
Gui, Ruirui
Li, Zhen
Zu, Yingling
Wang, Juan
Yu, Fengkuan
Zhang, Yanli
Zhao, Huifang
Ji, Zhenyu
Song, Yongping
author_facet Zhang, Binglei
Zhou, Jian
Gui, Ruirui
Li, Zhen
Zu, Yingling
Wang, Juan
Yu, Fengkuan
Zhang, Yanli
Zhao, Huifang
Ji, Zhenyu
Song, Yongping
author_sort Zhang, Binglei
collection PubMed
description Central nervous system (CNS) complications can occur in 9%–15% of patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The clinical manifestations of the CNS complications are non-specific, with most of them being disturbances of consciousness, convulsions, headaches, fever, and epilepsy, making it difficult to infer the cause of the complications based on clinical manifestations. We retrospectively analyzed the sensitivity and feasibility of metagenomic next generation sequencing (mNGS) in the diagnosis of CNS infections after allo-HSCT. Lumbar punctures were performed on 20 patients with CNS symptoms after receiving alternative donor HSCT(AD-HSCT) at the Affiliated Cancer Hospital of Zhengzhou University from February 2019 to December 2020, and their cerebrospinal fluid (CSF) was collected. The mNGS technique was used to detect pathogens in the CSF. Routine CSF testing, biochemical analyses, G experiments, GM experiments, ink staining, acid-fast staining, and bacterial cultures were carried out, and quantitative PCR (qPCR) tests were used to detect cytomegalovirus (CMV), Epstein-Barr virus (EBV), BK polyomavirus (BKPyV), and human alphaherpesvirus (HHV). A total of 29 tests were performed with 21 of them being positive. Of the five negative patients, three were diagnosed with a posterior reversible encephalopathy syndrome, one as having transplantation-associated thrombotic microangiopathy, and one with transient seizure caused by hypertension. Fifteen patients tested positive, of which four had single infections and eleven had mixed infections. Five cases of fungal infections, six cases of bacterial infections, and 13 cases of viral infections were detected. Among the 13 cases of viral infections, ten cases were CMV(HHV-5); three were BKPyV; two were Torque teno virus (TTV); Two were HHV-1,two were EBV(HHV4), and one each of HpyV5 and HHV-6B. Thirteen patients tested positive for virus while the qPCR detection method of 6 identical specimens were below the minimum detection limit(<1×10(3) U/ml). The mNGS technique is highly sensitive, and it can be used to diagnose CNS infections after allo-HSCT.
format Online
Article
Text
id pubmed-8476959
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84769592021-09-29 Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis Zhang, Binglei Zhou, Jian Gui, Ruirui Li, Zhen Zu, Yingling Wang, Juan Yu, Fengkuan Zhang, Yanli Zhao, Huifang Ji, Zhenyu Song, Yongping Front Cell Infect Microbiol Cellular and Infection Microbiology Central nervous system (CNS) complications can occur in 9%–15% of patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The clinical manifestations of the CNS complications are non-specific, with most of them being disturbances of consciousness, convulsions, headaches, fever, and epilepsy, making it difficult to infer the cause of the complications based on clinical manifestations. We retrospectively analyzed the sensitivity and feasibility of metagenomic next generation sequencing (mNGS) in the diagnosis of CNS infections after allo-HSCT. Lumbar punctures were performed on 20 patients with CNS symptoms after receiving alternative donor HSCT(AD-HSCT) at the Affiliated Cancer Hospital of Zhengzhou University from February 2019 to December 2020, and their cerebrospinal fluid (CSF) was collected. The mNGS technique was used to detect pathogens in the CSF. Routine CSF testing, biochemical analyses, G experiments, GM experiments, ink staining, acid-fast staining, and bacterial cultures were carried out, and quantitative PCR (qPCR) tests were used to detect cytomegalovirus (CMV), Epstein-Barr virus (EBV), BK polyomavirus (BKPyV), and human alphaherpesvirus (HHV). A total of 29 tests were performed with 21 of them being positive. Of the five negative patients, three were diagnosed with a posterior reversible encephalopathy syndrome, one as having transplantation-associated thrombotic microangiopathy, and one with transient seizure caused by hypertension. Fifteen patients tested positive, of which four had single infections and eleven had mixed infections. Five cases of fungal infections, six cases of bacterial infections, and 13 cases of viral infections were detected. Among the 13 cases of viral infections, ten cases were CMV(HHV-5); three were BKPyV; two were Torque teno virus (TTV); Two were HHV-1,two were EBV(HHV4), and one each of HpyV5 and HHV-6B. Thirteen patients tested positive for virus while the qPCR detection method of 6 identical specimens were below the minimum detection limit(<1×10(3) U/ml). The mNGS technique is highly sensitive, and it can be used to diagnose CNS infections after allo-HSCT. Frontiers Media S.A. 2021-09-14 /pmc/articles/PMC8476959/ /pubmed/34595132 http://dx.doi.org/10.3389/fcimb.2021.720132 Text en Copyright © 2021 Zhang, Zhou, Gui, Li, Zu, Wang, Yu, Zhang, Zhao, Ji and Song https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Zhang, Binglei
Zhou, Jian
Gui, Ruirui
Li, Zhen
Zu, Yingling
Wang, Juan
Yu, Fengkuan
Zhang, Yanli
Zhao, Huifang
Ji, Zhenyu
Song, Yongping
Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis
title Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis
title_full Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis
title_fullStr Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis
title_full_unstemmed Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis
title_short Metagenomic Next Generation Sequencing in the Detection of Pathogens in Cerebrospinal Fluid of Patients After Alternative Donor Transplantation: A Feasibility Analysis
title_sort metagenomic next generation sequencing in the detection of pathogens in cerebrospinal fluid of patients after alternative donor transplantation: a feasibility analysis
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476959/
https://www.ncbi.nlm.nih.gov/pubmed/34595132
http://dx.doi.org/10.3389/fcimb.2021.720132
work_keys_str_mv AT zhangbinglei metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis
AT zhoujian metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis
AT guiruirui metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis
AT lizhen metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis
AT zuyingling metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis
AT wangjuan metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis
AT yufengkuan metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis
AT zhangyanli metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis
AT zhaohuifang metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis
AT jizhenyu metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis
AT songyongping metagenomicnextgenerationsequencinginthedetectionofpathogensincerebrospinalfluidofpatientsafteralternativedonortransplantationafeasibilityanalysis